Recombinant Interleukin-24 Lacks Apoptosis-Inducing Properties in Melanoma Cells
2007

IL-24 Does Not Induce Apoptosis in Melanoma Cells

Sample size: 12 publication 10 minutes Evidence: high

Author Information

Author(s): Stephanie Kreis, Demetra Philippidou, Christiane Margue, Catherine Rolvering, Claude Haan, Laure Dumoutier, Jean-Christophe Renauld, Iris Behrmann

Primary Institution: University of Luxembourg

Hypothesis

Does IL-24 have cancer-specific apoptosis-inducing properties in melanoma cells?

Conclusion

The study concludes that IL-24 does not have cancer-specific apoptosis-inducing properties in melanoma cells.

Supporting Evidence

  • None of the melanoma cell lines expressed sufficient amounts of functional IL-24 receptors.
  • IL-24 did not induce apoptosis in any of the tested melanoma cell lines.
  • Previous studies reported conflicting results regarding IL-24's effects on melanoma cells.

Takeaway

Researchers tested a substance called IL-24 to see if it could kill melanoma cancer cells, but they found that it didn't work as expected.

Methodology

The study analyzed 12 melanoma cell lines for IL-24 receptor expression and apoptosis induction using various methods including RT-PCR, qPCR, and western blot.

Limitations

The study only tested a limited number of melanoma cell lines and did not explore all potential mechanisms of IL-24 action.

Digital Object Identifier (DOI)

10.1371/journal.pone.0001300

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication